linki2

Leeza Osipenko, PhD

leeza

Consilium Scientific CEO

Leeza gained experience in academia, consulting and public sector before establishing Consilium Scientific in 2020. After completing PhD in Systems Engineering in the USA, she came to England. Her career started at the University of Warwick Medical School where she worked as Senior Research Fellow on evaluating non-invasive foetal DNA tests. Then she relocated to London and joined a consulting company as Principal Economist leading on projects for NICE and other UK public sector departments. Leeza is an expert in Health Technology Assessment and between 2014 and 2018 she served as a Director of NICE Scientific Advice. Her academic work focuses on examining the status quo of clinical research, through quality improvement, transparency, and methodological rigour. In particular, she is interested in clinical data integrity, health policy, applied clinical research, and clinical trial design. Between 2018 and 2021 Leeza was a Senior Lecturer in Practice at the London School of Economics (LSE) Department of Health Policy and currently she is a Senior Visiting Fellow at LSE Health. Leeza serves on the Board of Directors at HealthSenseUK and ISRCTN, she is a non-resident expert at the Center for Global Development and she is on the Advisory Board at Egality.Health

07.10.2021 Clinical and Economic Data Transparency: Process vs. Evidence    Video | Slides | Learn More
24.02.2022 Who discovers medicines and what clinical benefit do they deliver to patients?  Video | Slides
10.11.2022 The waste in futile oncology drug development Video | Slides | Transcript
26.10.2023 Was Eli right about the dark heart of HTA? Video | Transcript
05.09.2024 Do we need Phase 3 trials in oncology? Video | Transcript
19.09.2024  Cancer and Alzheimer’s - can we prophesize the future of progress? Video

 

Search